Susan Galbraith

Susan Galbraith

Corporate Officer/Principal en ASTRAZENECA PLC .
Consumer Services
Health Technology
Finance

Perfil

Susan Mary Galbraith is currently Executive VP-Oncology Research & Development at AstraZeneca PLC since 2021, with employment at AstraZeneca PLC starting in 2010.
Former roles include Director at the American Association for Cancer Research from 2021 to 2024, Member-Supervisory Board at BB Biotech AG from 2020 to 2021, Independent Non-Executive Director at Horizon Discovery Group Ltd. from 2014 to 2020, and Vice President-Oncology & Clinical Biomarkers at Bristol-Myers Squibb Pharmaceuticals Ltd. in 2010.
Education includes undergraduate studies at The University of Manchester, graduate studies at the University of Cambridge, and a doctorate from the University of London.

Cargos activos de Susan Galbraith

EmpresasCargoInicio
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2010

Antiguos cargos conocidos de Susan Galbraith.

EmpresasCargoFin
Director/Miembro de la Junta 01/01/2024
BB BIOTECH AG Director/Miembro de la Junta 02/07/2021
HORIZON DISCOVERY GROUP PLC Director/Miembro de la Junta 30/04/2020
Corporate Officer/Principal 01/01/2010
Ver el detalle de la experiencia de Susan Galbraith.

Formación de Susan Galbraith.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

63

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Distribution Services